Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Dynamic interplay between RPL3- and RPL3L-containing ribosomes modulates mitochondrial activity in the mammalian heart

  • Milenkovic, Ivan
  • Santos Vieira, Helaine Graziele
  • Lucas, Morghan C.
  • Ruiz-Orera, Jorge
  • Patone, Giannino
  • Kesteven, Scott
  • Wu, Jianxin
  • Feneley, Michael
  • Espadas, Guadalupe
  • Sabidó Aguadé, Eduard, 1981-
  • Hübner, Norbert
  • van Heesch, Sebastiaan
  • Völkers, Mirko
  • Novoa, Eva Maria
The existence of naturally occurring ribosome heterogeneity is now a well-acknowledged phenomenon. However, whether this heterogeneity leads to functionally diverse 'specialized ribosomes' is still a controversial topic. Here, we explore the biological function of RPL3L (uL3L), a ribosomal protein (RP) paralogue of RPL3 (uL3) that is exclusively expressed in skeletal muscle and heart tissues, by generating a viable homozygous Rpl3l knockout mouse strain. We identify a rescue mechanism in which, upon RPL3L depletion, RPL3 becomes up-regulated, yielding RPL3-containing ribosomes instead of RPL3L-containing ribosomes that are typically found in cardiomyocytes. Using both ribosome profiling (Ribo-seq) and a novel orthogonal approach consisting of ribosome pulldown coupled to nanopore sequencing (Nano-TRAP), we find that RPL3L modulates neither translational efficiency nor ribosome affinity towards a specific subset of transcripts. In contrast, we show that depletion of RPL3L leads to increased ribosome-mitochondria interactions in cardiomyocytes, which is accompanied by a significant increase in ATP levels, potentially as a result of fine-tuning of mitochondrial activity. Our results demonstrate that the existence of tissue-specific RP paralogues does not necessarily lead to enhanced translation of specific transcripts or modulation of translational output. Instead, we reveal a complex cellular scenario in which RPL3L modulates the expression of RPL3, which in turn affects ribosomal subcellular localization and, ultimately, mitochondrial activity., The European Union's Horizon 2020 Research and Innovation Program under the Marie Skodowska-Curie grant agreement [713673]; the Australian Research Council [DE170100506 to E.M.N.]; the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) [PGC2018-098152-A-100 to E.M.N.]; the European Union Horizon 2020 Research and Innovation Program ERC advanced grant [AdG788970 to N.H.] and ERC starting grant [StG101042103 to E.M.N.]; the Leducq Foundation [16CVD03 to N.H.]; the Chan Zuckerberg Foundation [2019-20266 to N.H.]; and ‘la Caixa’ INPhINIT PhD fellowship [LCF/BQ/DI18/11660028 to I.M.]. We acknowledge the support of the MEIC to the EMBL partnership, Centro de Excelencia Severo Ochoa and CERCA Programme/Generalitat de Catalunya. The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech) and it is a member of the ProteoRed PRB3 consortium which is supported by grant PT17/0019 of the PE I + D + i 2013-2016 from the Instituto de Salud Carlos III (ISCIII) and ERDF. Conflict of interest statement. E.M.N. has received travel expenses from ONT to participate in nanopore conferences. I.M. has received a travel bursary from ONT to present his work in international conferences. E.M.N. is Scientific Advisory Board member for IMMAGINA Biotech. The authors declare that they have no competing interests.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

A trans locus causes a ribosomopathy in hypertrophic hearts that affects mRNA translation in a protein length-dependent fashion

  • Witte, Franziska
  • Ruiz Orera, Jorge
  • Ciolli Mattioli, Camilla
  • Blachut, Susanne
  • Adami, Eleonora
  • Felicitas Schulz, Jana
  • Schneider-Lunitz, Valentin
  • Hummel, Oliver
  • Patone, Giannino
  • Mücke, Michael Benedikt
  • Šilhavý, Jan
  • Heinig, Matthias
  • Bottolo, Leonardo
  • Sanchis, Daniel
  • Vingron, Martin
  • Chekulaeva, Marina
  • Pravenec, Michal
  • Hubner, Norbert
  • Van Heesch, Sebastiaan
Background: Little is known about the impact of trans-acting genetic variation on the rates with which proteins are synthesized by ribosomes. Here, we investigate the influence of such distant genetic loci on the efficiency of mRNA translation and define their contribution to the development of complex disease phenotypes within a panel of rat recombinant inbred lines. Results: We identify several tissue-specific master regulatory hotspots that each control the translation rates of multiple proteins. One of these loci is restricted to hypertrophic hearts, where it drives a translatome-wide and protein length-dependent change in translational efficiency, altering the stoichiometric translation rates of sarcomere proteins. Mechanistic dissection of this locus across multiple congenic lines points to a translation machinery defect, characterized by marked differences in polysome profiles and misregulation of the small nucleolar RNA SNORA48. Strikingly, from yeast to humans, we observe reproducible protein length-dependent shifts in translational efficiency as a conserved hallmark of translation machinery mutants, including those that cause ribosomopathies. Depending on the factor mutated, a pre-existing negative correlation between protein length and translation rates could either be enhanced or reduced, which we propose to result from mRNA-specific imbalances in canonical translation initiation and reinitiation rates. Conclusions: We show that distant genetic control of mRNA translation is abundant in mammalian tissues, exemplified by a single genomic locus that triggers a translation-driven molecular mechanism. Our work illustrates the complexity through which genetic variation can drive phenotypic variability between individuals and thereby contribute to complex disease., S.v.H. was supported by an EMBO long-term fellowship (ALTF 186-2015, LTFCOFUND2013, GA-2013-609409). N.H. is the recipient of an ERC advanced grant under the European Union Horizon 2020 Research and Innovation Program (grant agreement AdG788970) and is supported by a grant from the Leducq Foundation (16CVD03). M.P. was supported by Praemium Academiae award (AP1502) of the Czech Academy of Sciences. D.S. was funded by Grant 20153810 from Fundació La Marató de TV3. Open Access funding enabled and organized by Projekt DEAL.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A trans locus causes a ribosomopathy in hypertrophic hearts that affects mRNA translation in a protein length-dependent fashion

  • Witte, Franziska
  • Ruiz Orera, Jorge
  • Ciolli Mattioli, Camilla
  • Blachut, Susanne
  • Adami, Eleonora
  • Felicitas Schulz, Jana
  • Schneider-Lunitz, Valentin
  • Hummel, Oliver
  • Patone, Giannino
  • Mücke, Michael Benedikt
  • Šilhavý, Jan
  • Heinig, Matthias
  • Bottolo, Leonardo
  • Sanchis, Daniel
  • Vingron, Martin
  • Chekulaeva, Marina
  • Pravenec, Michal
  • Hubner, Norbert
  • Van Heesch, Sebastiaan
Background: Little is known about the impact of trans-acting genetic variation on the rates with which proteins are synthesized by ribosomes. Here, we investigate the influence of such distant genetic loci on the efficiency of mRNA translation and define their contribution to the development of complex disease phenotypes within a panel of rat recombinant inbred lines. Results: We identify several tissue-specific master regulatory hotspots that each control the translation rates of multiple proteins. One of these loci is restricted to hypertrophic hearts, where it drives a translatome-wide and protein length-dependent change in translational efficiency, altering the stoichiometric translation rates of sarcomere proteins. Mechanistic dissection of this locus across multiple congenic lines points to a translation machinery defect, characterized by marked differences in polysome profiles and misregulation of the small nucleolar RNA SNORA48. Strikingly, from yeast to humans, we observe reproducible protein length-dependent shifts in translational efficiency as a conserved hallmark of translation machinery mutants, including those that cause ribosomopathies. Depending on the factor mutated, a pre-existing negative correlation between protein length and translation rates could either be enhanced or reduced, which we propose to result from mRNA-specific imbalances in canonical translation initiation and reinitiation rates. Conclusions: We show that distant genetic control of mRNA translation is abundant in mammalian tissues, exemplified by a single genomic locus that triggers a translation-driven molecular mechanism. Our work illustrates the complexity through which genetic variation can drive phenotypic variability between individuals and thereby contribute to complex disease., S.v.H. was supported by an EMBO long-term fellowship (ALTF 186-2015, LTFCOFUND2013, GA-2013-609409). N.H. is the recipient of an ERC advanced grant under the European Union Horizon 2020 Research and Innovation Program (grant agreement AdG788970) and is supported by a grant from the Leducq Foundation (16CVD03). M.P. was supported by Praemium Academiae award (AP1502) of the Czech Academy of Sciences. D.S. was funded by Grant 20153810 from Fundació La Marató de TV3. Open Access funding enabled and organized by Projekt DEAL.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Dynamic interplay between RPL3- and RPL3L-containing ribosomes modulates mitochondrial activity in the mammalian heart

  • Milenkovic, Ivan
  • Santos Vieira, Helaine Graziele
  • Lucas, Morghan C.
  • Ruiz-Orera, Jorge
  • Patone, Giannino
  • Kesteven, Scott
  • Wu, Jianxin
  • Feneley, Michael
  • Espadas, Guadalupe
  • Sabidó Aguadé, Eduard, 1981-
  • Hübner, Norbert
  • van Heesch, Sebastiaan
  • Völkers, Mirko
  • Novoa, Eva Maria
The existence of naturally occurring ribosome heterogeneity is now a well-acknowledged phenomenon. However, whether this heterogeneity leads to functionally diverse 'specialized ribosomes' is still a controversial topic. Here, we explore the biological function of RPL3L (uL3L), a ribosomal protein (RP) paralogue of RPL3 (uL3) that is exclusively expressed in skeletal muscle and heart tissues, by generating a viable homozygous Rpl3l knockout mouse strain. We identify a rescue mechanism in which, upon RPL3L depletion, RPL3 becomes up-regulated, yielding RPL3-containing ribosomes instead of RPL3L-containing ribosomes that are typically found in cardiomyocytes. Using both ribosome profiling (Ribo-seq) and a novel orthogonal approach consisting of ribosome pulldown coupled to nanopore sequencing (Nano-TRAP), we find that RPL3L modulates neither translational efficiency nor ribosome affinity towards a specific subset of transcripts. In contrast, we show that depletion of RPL3L leads to increased ribosome-mitochondria interactions in cardiomyocytes, which is accompanied by a significant increase in ATP levels, potentially as a result of fine-tuning of mitochondrial activity. Our results demonstrate that the existence of tissue-specific RP paralogues does not necessarily lead to enhanced translation of specific transcripts or modulation of translational output. Instead, we reveal a complex cellular scenario in which RPL3L modulates the expression of RPL3, which in turn affects ribosomal subcellular localization and, ultimately, mitochondrial activity., The European Union's Horizon 2020 Research and Innovation Program under the Marie Skodowska-Curie grant agreement [713673]; the Australian Research Council [DE170100506 to E.M.N.]; the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) [PGC2018-098152-A-100 to E.M.N.]; the European Union Horizon 2020 Research and Innovation Program ERC advanced grant [AdG788970 to N.H.] and ERC starting grant [StG101042103 to E.M.N.]; the Leducq Foundation [16CVD03 to N.H.]; the Chan Zuckerberg Foundation [2019-20266 to N.H.]; and ‘la Caixa’ INPhINIT PhD fellowship [LCF/BQ/DI18/11660028 to I.M.]. We acknowledge the support of the MEIC to the EMBL partnership, Centro de Excelencia Severo Ochoa and CERCA Programme/Generalitat de Catalunya. The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech) and it is a member of the ProteoRed PRB3 consortium which is supported by grant PT17/0019 of the PE I + D + i 2013-2016 from the Instituto de Salud Carlos III (ISCIII) and ERDF. Conflict of interest statement. E.M.N. has received travel expenses from ONT to participate in nanopore conferences. I.M. has received a travel bursary from ONT to present his work in international conferences. E.M.N. is Scientific Advisory Board member for IMMAGINA Biotech. The authors declare that they have no competing interests.